Cellphire Revenue and Competitors

Location

$16M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Cellphire's estimated annual revenue is currently $5.2M per year.(i)
  • Cellphire's estimated revenue per employee is $77,500
  • Cellphire's total funding is $16M.

Employee Data

  • Cellphire has 67 Employees.(i)
  • Cellphire grew their employee count by 10% last year.

Cellphire's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
VP Discovery ResearchReveal Email/Phone
4
VP, Cryopreserved Platelets & Capital SupportReveal Email/Phone
5
VP Business OperationsReveal Email/Phone
6
VP Strategy & Investor Relations, Corporate SecretaryReveal Email/Phone
7
EVP R&D and OperationsReveal Email/Phone
8
VP, Head Clinical OperationsReveal Email/Phone
9
VP Business OperationsReveal Email/Phone
10
Associate Director Program ManagementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M2-60%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$9.6M62-15%N/AN/A
#6
$1.4M90%N/AN/A
#7
$2.5M160%N/AN/A
#8
$7.4M480%N/AN/A
#9
$0.2M1-83%N/AN/A
#10
$1.7M1122%N/AN/A
Add Company

What Is Cellphire?

Cellphire Therapeutics, Inc. is a Rockville, Maryland-based biotechnology company developing next-generation therapeutics. The company is applying its proprietary cell stabilization technology to all cell types, including platelets, to develop lifesaving products. Its lead product, Thrombosomes®, a freeze-dried hemostatic agent derived from human platelets, is currently in a Phase I clinical trial. Cellphire's technology has potential applications across a wide range of medical applications from trauma to wound care, imaging, targeted drug delivery, and regenerative medicine.

keywords:N/A

$16M

Total Funding

67

Number of Employees

$5.2M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cellphire News

2022-04-20 - Radiation Toxicity (Radiation Sickness, Acute Radiation ...

Aeolus Pharmaceuticals, Atox Bio Ltd, BCN Biosciences LLC, Cellphire Inc, Daiichi Sankyo Co Ltd, FirstString Research Inc, RxBio Inc,...

2022-03-22 - Cellphire Therapeutics Treats First Patient in Phase 2/3 ...

Cellphire Therapeutics, Inc. is a biotechnology company developing next-generation allogeneic cellular therapeutics. The company is applying its...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.2M6710%N/A
#2
$13.3M678%N/A
#3
$17.5M670%N/A
#4
$3.5M6826%N/A
#5
$12.5M68-8%N/A